Pilot Study of Gleevec/Imatinib Mesylate (STI-571, NSC 716051) in Neurofibromatosis (NF1) Patient With Plexiform Neurofibromas
Condition(s):Neurofibromatosis; NeurofibromasLast Updated:July 2, 2017Completed
Hide Studies Not Open or Pending
Condition(s):Neurofibromatosis; NeurofibromasLast Updated:July 2, 2017Completed
Condition(s):Acute Lymphoblastic Leukemia (ALL) Philadelphia Chromosome-positive (Ph+)Last Updated:March 26, 2013Suspended
Condition(s):Chronic Graft-versus-host DiseaseLast Updated:October 23, 2020Terminated
Condition(s):Gastrointestinal Stromal TumorsLast Updated:February 22, 2018Completed
Condition(s):Metastatic Gastrointestinal Stromal Tumor (GIST); C-KIT Mutation; Advanced Gastrointestinal Stromal Tumor (GIST)Last Updated:September 1, 2023Recruiting
Condition(s):ARDS; Acute Respiratory Distress Syndrome; Covid19; Endothelial Dysfunction; Pulmonary EdemaLast Updated:January 23, 2023Terminated
Condition(s):Progression-free Survival; Gastrointestinal Stromal Tumor; NeoadjuvantLast Updated:October 12, 2021Recruiting
Condition(s):Hypereosinophilic Syndrome; Systemic Mastocytosis; Chronic Myelomonocytic Leukemia; DermatofibrosarcomaLast Updated:February 23, 2017Completed
Condition(s):Chronic Myeloid Leukemia; Gastrointestinal Stromal TumorLast Updated:October 1, 2014Completed
Condition(s):Nephrogenic Systemic FibrosisLast Updated:May 19, 2017Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.